Wikidata

(Q41713661)

English

Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study

scientific article published on January 2000

In more languages

Statements

title
Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10631622
retrieved
7 October 2017
publication date
1 January 2000
1 reference
stated in
Europe PubMed Central
PubMed ID
10631622
retrieved
7 October 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q41713661&oldid=2119766850"